Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $54.1 million.

  • Fortress Biotech's Total Current Liabilities fell 2309.65% to $54.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.1 million, marking a year-over-year decrease of 2309.65%. This contributed to the annual value of $71.4 million for FY2024, which is 1591.02% down from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Total Current Liabilities is $54.1 million, which was down 2309.65% from $57.5 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Total Current Liabilities registered a high of $129.5 million during Q1 2023, and its lowest value of $53.8 million during Q1 2021.
  • Over the past 5 years, Fortress Biotech's median Total Current Liabilities value was $87.7 million (recorded in 2024), while the average stood at $89.5 million.
  • In the last 5 years, Fortress Biotech's Total Current Liabilities skyrocketed by 17685.15% in 2021 and then tumbled by 4124.96% in 2024.
  • Quarter analysis of 5 years shows Fortress Biotech's Total Current Liabilities stood at $101.0 million in 2021, then increased by 26.4% to $127.7 million in 2022, then plummeted by 33.52% to $84.9 million in 2023, then dropped by 15.91% to $71.4 million in 2024, then dropped by 24.27% to $54.1 million in 2025.
  • Its Total Current Liabilities was $54.1 million in Q3 2025, compared to $57.5 million in Q2 2025 and $73.7 million in Q1 2025.